Related Experiment Videos
Lupus-like syndrome--a rare complication in thionamide treatment for Graves' disease
Abstract:
A patient with Graves' disease who experienced various allergic reactions to both PTU and MMI is reported. She developed fever, skin rash, lymphadenopathy, liver damage and moderate leukopenia during PTU administration. Furthermore, she developed an MMI-induced lupus-like syndrome characterized by generalized lymphadenopathy, migrating, polyarthritis and myalgia, and results of tests for anti-DNA antibody and anti-nuclear antibody, and LE were positive. All these abnormalities reverted to normal upon discontinuation of medication after subtotal thyroidectomy.
Insights
This case report details a Graves' disease patient experiencing severe allergic reactions to both propylthiouracil (PTU) and methimazole (MMI). Both drugs caused significant adverse effects, highlighting the need for careful monitoring in patients with Graves' disease.
Area of Science:
- Endocrinology
- Clinical Pharmacology
Background:
- Graves' disease is a common cause of hyperthyroidism.
- Propylthiouracil (PTU) and methimazole (MMI) are primary medical treatments for Graves' disease.
- Adverse reactions to antithyroid drugs can limit treatment options.